These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2545964)

  • 41. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
    Shahid M; Nicholson CD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
    Brunkhorst D; v der Leyen H; Meyer W; Nigbur R; Schmidt-Schumacher C; Scholz H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart.
    Sys SU; Boels PJ; Brutsaert DL
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):445-9. PubMed ID: 2444798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    Kitada Y; Narimatsu A; Suzuki R; Endoh M; Taira N
    J Pharmacol Exp Ther; 1987 Nov; 243(2):639-45. PubMed ID: 2824754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antagonism towards endogenous adenosine and inhibition of cGI-PDE in the cardiac effects of amrinone, milrinone and related analogues.
    Dorigo P; Gaion RM; Belluco P; Borea PA; Guerra L; Mosti L; Floreani M; Carpenedo F
    Gen Pharmacol; 1992 May; 23(3):535-41. PubMed ID: 1324870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cyclopiazonic acid, an inhibitor of sarcoplasmic reticulum Ca(2+)-ATPase, on the frequency-dependence of the contraction-relaxation cycle of the guinea-pig isolated atrium.
    Yard NJ; Chiesi M; Ball HA
    Br J Pharmacol; 1994 Nov; 113(3):1001-7. PubMed ID: 7858841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the perfusion of amrinone and milrinone on the ventricular fibrillation thresholds in isolated Langendorff perfused guinea-pig hearts.
    Cuparencu B; Tomuş C; Feştilă C
    Rev Roum Physiol (1990); 1990; 27(1):9-13. PubMed ID: 2094351
    [No Abstract]   [Full Text] [Related]  

  • 49. Pyridazine analogues of biologically active compounds. Part 5: Novel potential cardiotonics of the amrinone type.
    Haider N; Heinisch G; Offenberger S
    Pharmazie; 1989 Sep; 44(9):598-601. PubMed ID: 2608703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
    Temma K; Akera T; Brody TM; Rech RH
    J Pharmacol Exp Ther; 1983 Sep; 226(3):885-92. PubMed ID: 6887016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Scholz H; Meyer W
    Circulation; 1986 Mar; 73(3 Pt 2):III99-108. PubMed ID: 2417748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for an intracellular site of action in the heart for two hydrophobic cardiac steroids.
    Núñez-Durán H; Fernández P
    Life Sci; 2004 Jan; 74(11):1337-44. PubMed ID: 14706565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac and coronary vasodilator effects of the novel cardiotonic agent, MCI-154, assessed in isolated, blood-perfused dog heart preparations.
    Hosono M; Taira N
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):692-8. PubMed ID: 2450240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of extracellular Ca2+ and related ions on the cardiac action of milrinone.
    Farah AE; Canniff PC; Bentley RG; Frangakis CJ
    J Cardiovasc Pharmacol; 1988 May; 11(5):591-600. PubMed ID: 2455846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical studies on the mechanism of cardiotonic activity of MDL 17,043.
    Kariya T; Wille LJ; Dage RC
    J Cardiovasc Pharmacol; 1982; 4(3):509-14. PubMed ID: 6177950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial actions of milrinone: characterization of its mechanism of action.
    Rapundalo ST; Grupp I; Grupp G; Abdul Matlib M; Solaro RJ; Schwartz A
    Circulation; 1986 Mar; 73(3 Pt 2):III134-44. PubMed ID: 2417746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial fibers in endotoxic shock rats.
    Ming MJ; Hu D; Chen HS; Liu LM; Nan X; Hua CH; Lu RQ
    Shock; 2000 Dec; 14(6):652-6. PubMed ID: 11131917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS; Eardley D; Watkins R; Prioli N
    Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
    Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
    Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.